Trial to Compare Two Strains of BCG

PHASE4CompletedINTERVENTIONAL
Enrollment

16,390

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

October 30, 2022

Study Completion Date

December 1, 2022

Conditions
Death, InfantMorbidity;Infant
Interventions
BIOLOGICAL

BCG-Japan

Infant (\<1 year) 0.05 ml dose of resuspended BCG-Japan (Tokyo strain 172, Japan BCG Laboratory, 1-5-21 Otsuka, Bunkyo-ku, Tokyo, 112-0012 Japan).

BIOLOGICAL

BCG-Russia

Infant (\<1 year) 0.05 ml dose of resuspended BCG-Russia (Serum Institute of India)

Trial Locations (1)

Unknown

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

lead

Bandim Health Project

OTHER

NCT04383925 - Trial to Compare Two Strains of BCG | Biotech Hunter | Biotech Hunter